NO903058L - Farmasoeytisk preparat med forbedret absorberbarhet. - Google Patents

Farmasoeytisk preparat med forbedret absorberbarhet.

Info

Publication number
NO903058L
NO903058L NO90903058A NO903058A NO903058L NO 903058 L NO903058 L NO 903058L NO 90903058 A NO90903058 A NO 90903058A NO 903058 A NO903058 A NO 903058A NO 903058 L NO903058 L NO 903058L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
improved absorbability
absorbability
improved
chem
Prior art date
Application number
NO90903058A
Other languages
English (en)
Other versions
NO903058D0 (no
NO177484B (no
NO177484C (no
Inventor
Keizo Uesugi
Masanori Kayano
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO903058D0 publication Critical patent/NO903058D0/no
Publication of NO903058L publication Critical patent/NO903058L/no
Publication of NO177484B publication Critical patent/NO177484B/no
Publication of NO177484C publication Critical patent/NO177484C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO903058A 1989-07-10 1990-07-09 Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler NO177484C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17732489 1989-07-10

Publications (4)

Publication Number Publication Date
NO903058D0 NO903058D0 (no) 1990-07-09
NO903058L true NO903058L (no) 1991-01-11
NO177484B NO177484B (no) 1995-06-19
NO177484C NO177484C (no) 1995-09-27

Family

ID=16028989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903058A NO177484C (no) 1989-07-10 1990-07-09 Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler

Country Status (13)

Country Link
US (1) US5139740A (no)
EP (1) EP0407815B1 (no)
JP (1) JP3048602B2 (no)
KR (1) KR930000048B1 (no)
CN (1) CN1041600C (no)
AT (1) ATE88902T1 (no)
CA (1) CA2020261A1 (no)
DE (1) DE69001513T2 (no)
DK (1) DK0407815T3 (no)
ES (1) ES2055227T3 (no)
FI (1) FI96169C (no)
GR (1) GR3007793T3 (no)
NO (1) NO177484C (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI901046A0 (fi) * 1989-03-17 1990-03-01 Eisai Co Ltd Stabilisering av polyprenylfoereningen.
WO1992017185A1 (en) * 1991-03-29 1992-10-15 University Of Florida Targeted drug delivery via mixed phosphate derivatives
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
US5880163A (en) * 1996-12-12 1999-03-09 Pharmacia & Upjohn Company Oil composition of dihydropolyprenols
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
AU2004264958B2 (en) 2003-08-13 2010-04-15 Biocon, Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
US9730884B2 (en) * 2011-09-29 2017-08-15 Plx Opco Inc. pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド ｐＨ依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2746087A1 (de) * 1977-10-13 1979-04-26 Chinoin Gyogyszer Es Vegyeszet Cyclodextrin-einschlusskomplexe mit indomethacin, verfahren zu ihrer herstellung und pharmazeutische mittel
JPS5815940A (ja) * 1981-07-23 1983-01-29 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
JPS58172366A (ja) * 1982-04-01 1983-10-11 Kaken Pharmaceut Co Ltd インド−ル酢酸ポリプレニルエステル誘導体、その製造法およびそれを有効成分とする解熱鎮痛消炎剤
DE3500103C2 (de) * 1985-01-04 1987-01-22 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems

Also Published As

Publication number Publication date
EP0407815A2 (en) 1991-01-16
DE69001513T2 (de) 1993-10-28
NO903058D0 (no) 1990-07-09
US5139740A (en) 1992-08-18
DE69001513D1 (de) 1993-06-09
FI96169B (fi) 1996-02-15
FI96169C (fi) 1996-05-27
NO177484B (no) 1995-06-19
EP0407815A3 (en) 1991-02-27
NO177484C (no) 1995-09-27
GR3007793T3 (no) 1993-08-31
CN1041600C (zh) 1999-01-13
KR930000048B1 (ko) 1993-01-06
EP0407815B1 (en) 1993-05-05
DK0407815T3 (da) 1993-06-01
FI903030A0 (fi) 1990-06-15
CN1048656A (zh) 1991-01-23
CA2020261A1 (en) 1991-01-11
KR910002443A (ko) 1991-02-25
ATE88902T1 (de) 1993-05-15
ES2055227T3 (es) 1994-08-16
JPH03128322A (ja) 1991-05-31
JP3048602B2 (ja) 2000-06-05

Similar Documents

Publication Publication Date Title
NO2002009I2 (no) Tiotropium
DK232989A (da) Antiviralt praeparat
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
IT1228288B (it) Composti ad attivita' antiserotoninica
SE8600017L (sv) Ny forening
NO903058L (no) Farmasoeytisk preparat med forbedret absorberbarhet.
DE69001734D1 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
EP0103320A3 (en) Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them
GR3017599T3 (en) Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them.
NO883520L (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
PT87628A (pt) Process for the preparation of a fungicidal composition cintaining (2-cyano-2-oxyminoacetyl)-aminoacids derivatives
DE69108580D1 (de) Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen.
CA2022323A1 (en) Excretion of potassium ion by prostanoic acid derivatives
EP0080592B1 (en) A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
ATE130841T1 (de) Ursane derivate, ihre herstellung und die enthaltende pharmazeutische zusammensetzung.
NO178137C (no) Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler
DE69011174D1 (de) Catecholaminester.